We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Information and documents on Public Health England’s review of the evidence for dependence on, and withdrawal from, prescribed medicines.
How to apply for, update and cancel licences for the manufacture, import and wholesale of human and veterinary medicines.
The MHRA is undertaking a public consultation on proposals to end the 'sell through' of unlicensed herbal remedies legally on market at April 2011.
A list of herbal ingredients which are banned or restricted for unlicensed medicines.
Comply with good manufacturing practice (GMP) and good distribution practice (GDP), and prepare for an inspection.
Guidance on medicines for food and non-food horses and record keeping requirements including the horse passport.
The committee advises on the safety and quality of herbal medicines when there's an application for registration, marketing authorisation or product licence.
Marketing Authorisation Holders should review their manufacturing processes to identify and, if found, to mitigate the risk of nitrosamine impurities being present.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Reported problems with the supply of an animal medicine and the date when the issue is expected to be resolved.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines in the UK.
Guidance on applications and licences for manufacturers & wholesalers, suspended and revoked licences, registrations, exporting medicines, defective medicinal products and fees.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Guidance for veterinary medicines manufacturers and wholesale dealers in GB on selling and supplying products placed on the EU and UK markets before 1 January 2021 and the evidence you may need to provide.
Details of the process changes for established medicines, effective from 1 March 2024, which apply specifically to chemical products.
Cancel a marketing authorisation, traditional herbal registration or parallel import product licence or withdraw a pending submission.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
The MHRA will review applications for orphan designation at the time of a marketing authorisation (MA) or variation application.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).